ArticleClinical rheumatology2026
Correlation between perivascular spaces and clinical features in patients with rheumatoid arthritis.
Article in Clinical rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aims to compare perivascular space (PVS) parameters across different rheumatoid factor (RF) titer subgroups within a rheumatoid arthritis (RA) cohort, and to explore their correlations with serological markers.
methodsIn this cross-sectional study, 160 RA patients were enrolled and categorized into three groups based on RF titer: the negative group (n = 35), the low-titer group (n = 26), and the high-titer group (n = 99). Demographic, clinical, and laboratory data were systematically collected. PVS parameters across various brain regions were quantitatively assessed using 3.0 T magnetic resonance imaging (MRI). Spearman correlation analysis was employed to explore associations, and multiple linear regression was conducted for multivariate analysis.
resultsStatistically significant differences were identified among the three groups concerning the number of PVS in the right frontal lobe (p = 0.022), the number of PVS in the right parietal lobe (p = 0.032), the volume of PVS in the right parietal lobe (p = 0.004), and the number of PVS in the pons (p = 0.006). The high-titer group exhibited significantly elevated values of the frontal and parietal PVS parameters compared to the negative group (all p < 0.05). Correlation analysis demonstrated that RF-IgA showed weak-to-moderate but statistically significant positive correlations with the number of PVS in the right frontal lobe (R = 0.181), the number of PVS in the right parietal lobe (R = 0.193), and the volume of PVS in the right parietal lobe (R = 0.162) (all p < 0.05). Additionally, the anti-cyclic citrullinated peptide III antibody (Anti-CCPIII) was positively correlated with the number of PVS in the right parietal lobe (R = 0.196), while the anti-mutated citrullinated vimentin antibody (MCV) was positively correlated with the number of PVS in the pons (R = 0.168) (all p < 0.05). Multiple regression analysis revealed that the erythrocyte sedimentation rate (ESR) was independently negatively associated with the number of PVS in the right frontal lobe (β = - 0.142, p = 0.022). In conclusion, autoantibody titers and inflammatory levels in RA patients are linked to PVS enlargement in specific brain regions. These intra-group differences suggest that PVS burden varies with autoimmune load in RA patients, highlighting its potential as a surrogate imaging marker for immune-mediated cerebral microvascular involvement within the RA population.
conclusionThis study demonstrates that distinct autoantibody profiles in RA correlate with region-specific enlargement of PVS. Perivascular space abnormalities may potentially serve as a non-invasive imaging marker to reflect immune-mediated cerebral small vessel injury. Longitudinal multicenter trials with cognitive assessments are required to further validate the association and explore the therapeutic effects of immune regulation on brain microvascular lesions. Key Points • This study quantitatively analyzed PVS via 3.0 T MRI in 160 RA patients grouped by rheumatoid factor titers. • High RF titer was significantly correlated with increased PVS number and volume in the right frontal and parietal lobes, while pontine PVS peaked in the low-titer group. • RA-related autoantibodies including RF-IgA, anti-CCPIII and MCV showed positive correlations with region-specific PVS enlargement, independent of traditional vascular risk factors. • PVS may be considered a potential non-invasive imaging biomarker for early identification and risk stratification of RA-associated cerebral small vessel injury.
Indexed as
Identifiers
42690513What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.